Sagefield Capital LP Horizon Therapeutics Public LTD CO Transaction History

Sagefield Capital LP

  • $769 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$98.98 - $115.74 $920,514 - $1.08 Million
9,300 Added 238.46%
13,200 $1.53 Million
Q2 2023

Aug 14, 2023
SELL
$96.34 - $112.38 $356,458 - $415,806
-3,700 Reduced 48.68%
3,900 $401,000
Q1 2023

May 15, 2023
SELL
$107.32 - $113.5 $944,415 - $998,800
-8,800 Reduced 53.66%
7,600 $829,000
Q4 2022

Feb 14, 2023
BUY
$62.39 - $113.8 $1.02 Million - $1.87 Million
16,400 New
16,400 $1.87 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Sagefield Capital LP Portfolio

Follow Sagefield Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sagefield Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sagefield Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email